Showing results (61-70 of 85) with videos related to

Sort By:
Pageof 9
Acta Crystallographica. Section F, Structural Biology and Crystallization Communications|November 2, 2006
Structure of the ligand-binding domain (LBD) of human androgen receptor in complex with a selective modulator LGD2226Feng Wang, Xiao-qin Liu, He Li, et al.
Journal of Clinical Pharmacology|May 8, 2018
Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Allopurinol in Adult Male Subjects With GoutMartin Kankam, Jesse Hall, Michael Gillen, et al.
Bioorganic & Medicinal Chemistry Letters|December 1, 2010
Tetrahydroquinoline glucocorticoid receptor agonists: discovery of a 3-hydroxyl for improving receptor selectivitySteven L Roach, Robert I Higuchi, Andrew R Hudson, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2007
Antiinflammatory glucocorticoid receptor ligand with reduced side effects exhibits an altered protein-protein interaction profileJeffrey N Miner, Bob Ardecky, Khalid Benbatoul, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Discovery of orally available tetrahydroquinoline-based glucocorticoid receptor agonistsAndrew R Hudson, Robert I Higuchi, Steven L Roach, et al.
Arthritis Research & Therapy|May 4, 2018
Accuracy of the HumaSensplus point-of-care uric acid meter using capillary blood obtained by fingertip punctureStéphanie Fabre, Pierre Clerson, Jean-Marie Launay, et al.
Cancer Research|August 27, 2009
RDEA119/BAY 869766: a potent, selective, allosteric inhibitor of MEK1/2 for the treatment of cancerCory Iverson, Gary Larson, Chon Lai, et al.
Endocrinology|March 14, 2009
Sexual differentiation of the spinal nucleus of the bulbocavernosus is not mediated solely by androgen receptors in muscle fibersLee Niel, Amit H Shah, Gareth A Lewis, et al.
Arthritis Research & Therapy|October 8, 2016
Lesinurad, a novel, oral compound for gout, acts to decrease serum uric acid through inhibition of urate transporters in the kidneyJeffrey N Miner, Philip K Tan, David Hyndman, et al.
Molecular Pharmacology|July 20, 2002
trans-Activation and repression properties of the novel nonsteroid glucocorticoid receptor ligand 2,5-dihydro-9-hydroxy-10-methoxy-2,2,4-trimethyl-5-(1-methylcyclohexen-3-y1)-1H-[1]benzopyrano[3,4-f]quinoline (A276575) and its four stereoisomersChun Wel Lin, Masaki Nakane, Mike Stashko, et al.
Pageof 9